Ohoud J. Alotaibi

453 citations

9 papers · 371 indexed · h-index 9

Organic Chemistry top 10%
- Synthesis and biological activity 5
- Synthesis and Catalytic Reactions 4
- Synthesis and Characterization of Heterocyclic Compounds 2
Toxicology top 10%
- Bioactive Compounds and Antitumor Agents 1
Cancer Research
Molecular Biology
- Enzyme function and inhibition 3
- Cancer therapeutics and mechanisms 2
Pharmacology
Pathology and Forensic Medicine
- Cancer Mechanisms and Therapy 1
Complementary and alternative medicine
- Phytochemicals and Medicinal Plants 1

Co-authors: Tarfah Al‐Warhi Wagdy M. Eldehna Hatem A. Abdel‐Aziz Nada Aljaeed Mahmoud M. Elaasser Mohammad M. Al‐Sanea Claudiu T. Supuran Alessio Nocentini
Cited by: Organic Chemistry Toxicology Cancer Research
Journals: Molecules (1 paper)Antibiotics (1 paper)Pharmaceuticals (1 paper)
Partner nations: Egypt Saudi Arabia United Kingdom

In The Last Decade

Ohoud J. Alotaibi

9 papers receiving 369 citations

Peers

Countries citing papers authored by Ohoud J. Alotaibi

Since Specialization

Citations

This map shows the geographic impact of Ohoud J. Alotaibi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ohoud J. Alotaibi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ohoud J. Alotaibi more than expected).

Fields of papers citing papers by Ohoud J. Alotaibi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ohoud J. Alotaibi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ohoud J. Alotaibi. The network helps show where Ohoud J. Alotaibi may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ohoud J. Alotaibi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ohoud J. Alotaibi Line = papers co-authored together Ohoud J. Alotaibi links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work
1	1-Benzyl-5-bromo-3-hydrazonoindolin-2-ones as Novel Anticancer Agents: Synthesis, Biological Evaluation and Molecular Modeling Insights Molecules ·Tarfah Al‐Warhi,Hadia Almahli,Raed M. Maklad,Zainab M. Elsayed,Mahmoud A. El Hassab,Ohoud J. Alotaibi,Nada Aljaeed,Rezk R. Ayyad,Hazem A. Ghabour,Wagdy M. Eldehna,Mohamed K. El‐Ashrey	2023	16
2	Discovery of 2,4-thiazolidinedione-tethered coumarins as novel selective inhibitors for carbonic anhydrase IX and XII isoforms Figshare ·Wagdy M. Eldehna,Mohammed S. Taghour,Tarfah Al‐Warhi,Alessio Nocentini,Mostafa M. Elbadawi,Hazem A. Mahdy,Mohamed A. Abdelrahman,Ohoud J. Alotaibi,Nada Aljaeed,Diaaeldin M. Elimam,Kamyar Afarinkia,Hatem A. Abdel‐Aziz,Claudiu T. Supuran	2022	29
3	Design and synthesis of benzothiazole-based SLC-0111 analogues as new inhibitors for the cancer-associated carbonic anhydrase isoforms IX and XII Journal of Enzyme Inhibition and Medicinal Chemistry ·Tarfah Al‐Warhi,Mostafa M. Elbadawi,Alessandro Bonardi,Alessio Nocentini,Ahmed A. Al‐Karmalawy,Nada Aljaeed,Ohoud J. Alotaibi,Hatem A. Abdel‐Aziz,Claudiu T. Supuran,Wagdy M. Eldehna	2022	40
4	Identification of Novel Cyanopyridones and Pyrido[2,3-d]Pyrimidines as Anticancer Agents with Dual VEGFR-2/HER-2 Inhibitory Action: Synthesis, Biological Evaluation and Molecular Docking Studies Pharmaceuticals ·Tarfah Al‐Warhi,Al-Aliaa M. Sallam,Loah R. Hemeda,Mahmoud A. El Hassab,Nada Aljaeed,Ohoud J. Alotaibi,Ahmed S. Doghish,Mina Noshy,Wagdy M. Eldehna,Mona H. Ibrahim	2022	62
5	Strawberry and Ginger Silver Nanoparticles as Potential Inhibitors for SARS-CoV-2 Assisted by In Silico Modeling and Metabolic Profiling Antibiotics ·Mohammad M. Al‐Sanea,Narek Abelyan,Mohamed A. Abdelgawad,Arafa Musa,Mohammed M. Ghoneim,Tarfah Al‐Warhi,Nada Aljaeed,Ohoud J. Alotaibi,Taghreed S. Alnusaire,Sayed F. Abdelwahab,Aya Helmy,Usama Ramadan Abdelmohsen,Khayrya A. Youssif	2021	37
6	New Benzoxazole Derivatives as Antiprotozoal Agents: In Silico Studies, Synthesis, and Biological Evaluation Journal of Chemistry ·Mohamed A. Abdelgawad,Mohammad M. Al‐Sanea,Mohamed A. Zaki,Enas Mohamed,Shabana I. Khan,Babu L. Tekwani,Amar G. Chittiboyina,Ikhlas A. Khan,Tarfah Al‐Warhi,Nada Aljaeed,Ohoud J. Alotaibi,Abdulsalam A. M. Alkhaldi,Heba A.H. Elshemy	2021	9
7	Benzofuran-Based Carboxylic Acids as Carbonic Anhydrase Inhibitors and Antiproliferative Agents against Breast Cancer ACS Medicinal Chemistry Letters ·Wagdy M. Eldehna,Alessio Nocentini,Zainab M. Elsayed,Tarfah Al‐Warhi,Nada Aljaeed,Ohoud J. Alotaibi,Mohammad M. Al‐Sanea,Hatem A. Abdel‐Aziz,Claudiu T. Supuran	2020	55
8	Novel [(N-alkyl-3-indolylmethylene)hydrazono]oxindoles arrest cell cycle and induce cell apoptosis by inhibiting CDK2 and Bcl-2: synthesis, biological evaluation and in silico studies Journal of Enzyme Inhibition and Medicinal Chemistry ·Tarfah Al‐Warhi,Mahmoud F. Abo-Ashour,Hadia Almahli,Ohoud J. Alotaibi,Mohammad M. Al‐Sanea,Ghada H. Al-Ansary,Hanaa Y. Ahmed,Mahmoud M. Elaasser,Wagdy M. Eldehna,Hatem A. Abdel‐Aziz	2020	56
9	Discovery of 3,6-disubstituted pyridazines as a novel class of anticancer agents targeting cyclin-dependent kinase 2: synthesis, biological evaluation and in silico insights Journal of Enzyme Inhibition and Medicinal Chemistry ·Ahmed Sabt,Wagdy M. Eldehna,Tarfah Al‐Warhi,Ohoud J. Alotaibi,Mahmoud M. Elaasser,Howayda Suliman,Hatem A. Abdel‐Aziz	2020	67

About Ohoud J. Alotaibi

Ohoud J. Alotaibi is a scholar working on Toxicology, Organic Chemistry and Complementary and alternative medicine, having authored 9 papers that have together received 371 indexed citations. Recurring topics across this work include Synthesis and biological activity (5 papers), Synthesis and Catalytic Reactions (4 papers), Enzyme function and inhibition (3 papers), Cancer therapeutics and mechanisms (2 papers), Synthesis and Characterization of Heterocyclic Compounds (2 papers), Bioactive Compounds and Antitumor Agents (1 paper), Cancer Mechanisms and Therapy (1 paper) and Phytochemicals and Medicinal Plants (1 paper). The work is most often cited by research in Organic Chemistry (235 citations), Toxicology (25 citations) and Cancer Research (47 citations). Ohoud J. Alotaibi has collaborated with scholars based in Egypt, Saudi Arabia and United Kingdom. Frequent co-authors include Tarfah Al‐Warhi, Wagdy M. Eldehna, Hatem A. Abdel‐Aziz, Nada Aljaeed, Mahmoud M. Elaasser, Mohammad M. Al‐Sanea, Claudiu T. Supuran, Alessio Nocentini, Ahmed Sabt and Zainab M. Elsayed. Their work appears in journals such as Molecules, Antibiotics and Pharmaceuticals.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact